At the news
? NEUTRALIMPACT 2/10 COURT-RULING filed Mar 1, 2026 at 19:00 ET
The court granted in part Kaiser's request to take additional depositions of Merck (including a 30(b)(6) deposition on Vytorin-related topics and two former employees) after remand from the Zetia MDL, but denied two topics related to Orange Book patent listings. This is a routine procedural discovery order that does not resolve any substantive claims or impose financial liability.
- Kaiser may take a 30(b)(6) deposition of Merck on 8 of 10 proposed topics related to Vytorin pricing, marketing, and strategy
- Kaiser may depose two former Merck employees (Glen Firestone and Paul McCrorey) as fact witnesses
- Two topics regarding Orange Book listings of the '966 and '106 patents were denied without prejudice
- The court found the Vytorin claims are substantially different from the Zetia claims that were the focus of the MDL
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access